PDE5 inhibitors, such as sildenafil, tadalafil, and vardenafil, are the first-line oral drugs recommended by the World Health Organization (WHO) for the treatment of erectile dysfunction, including that associated with diabetes (23–25). This evidence concerns the gene PDE5A and erectile dysfunction.